Clinical next-generation sequencing in patients with non-small cell lung cancer.
about
ALK evaluation in the world of multiplex testing: Network Genomic Medicine (NGM): the Cologne model for implementing personalised oncologyNext-Generation Sequencing in Clinical Molecular Diagnostics of Cancer: Advantages and ChallengesThe possibility of clinical sequencing in the management of cancerClinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer.Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.Evaluation of two highly-multiplexed custom panels for massively parallel semiconductor sequencing on paraffin DNAIdentification of major factors associated with failed clinical molecular oncology testing performed by next generation sequencing (NGS).Combined Targeted DNA Sequencing in Non-Small Cell Lung Cancer (NSCLC) Using UNCseq and NGScopy, and RNA Sequencing Using UNCqeR for the Detection of Genetic Aberrations in NSCLC.Utility of different massive parallel sequencing platforms for mutation profiling in clinical samples and identification of pitfalls using FFPE tissueAnalytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNAMutAid: Sanger and NGS Based Integrated Pipeline for Mutation Identification, Validation and Annotation in Human Molecular Genetics.Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded MaterialValidation and Application of a Custom-Designed Targeted Next-Generation Sequencing Panel for the Diagnostic Mutational Profiling of Solid Tumors.Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical TrialsIntegration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies.Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung.Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.Experience with targeted next generation sequencing for the care of lung cancer: insights into promises and limitations of genomic oncology in day-to-day practice.DaMold: A data-mining platform for variant annotation and visualization in molecular diagnostics research.Upfront molecular testing in patients with advanced gastro-esophageal cancer: Is it time yet?Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ Platform.High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer.Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients.Use of dedicated gene panel sequencing using next generation sequencing to improve the personalized care of lung cancer.Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis.Comprehensive profiling and quantitation of oncogenic mutations in non small-cell lung carcinoma using single molecule amplification and re-sequencing technology.Next-generation sequencing of non-small cell lung cancer using a customized, targeted sequencing panel: Emphasis on small biopsy and cytology.Clinical application of amplicon-based next-generation sequencing to therapeutic decision making in lung cancer.Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma.FGFR2 Amplification in Colorectal Adenocarcinoma.Massive parallel sequencing of solid tumours - challenges and opportunities for pathologists.A Pilot Study of Clinical Targeted Next Generation Sequencing for Prostate Cancer: Consequences for Treatment and Genetic Counseling.Real-Time Genomic Characterization Utilizing Circulating Cell-Free DNA in Patients with Anaplastic Thyroid Carcinoma.The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics.ALK in Non-Small Cell Lung Cancer (NSCLC) Pathobiology, Epidemiology, Detection from Tumor Tissue and Algorithm Diagnosis in a Daily Practice.ALK+ lung adenocarcinoma in never smokers and long-term ex-smokers: prevalence and detection by immunohistochemistry and fluorescence in situ hybridization.Estrogen, Estrogen Receptor and Lung CancerEstimation of age-related DNA degradation from formalin-fixed and paraffin-embedded tissue according to the extraction methodsDiscrimination of Germline EGFR T790M Mutations in Plasma Cell-Free DNA Allows Study of Prevalence Across 31,414 Cancer Patients.Comparison of cross-platform technologies for EGFR T790M testing in patients with non-small cell lung cancer.
P2860
Q26738387-A299D429-D8C2-4322-87C7-6C58879179FBQ26782324-ED19DF13-94B4-45D6-BDA4-344CAC46AA54Q28072144-06C8D644-3252-4239-8EC1-1F07DF577470Q33798605-190907F7-DDAC-4048-AB48-D2AC1AB69725Q34550417-CA8472E2-E13D-45FA-8B65-BC3FD63673A1Q35651423-9DCB293E-F02C-4230-8418-CDCCE0436631Q35662768-6CA456FE-4A03-4789-9399-FC8AFDD84541Q35664233-A20FB1D4-6163-44D2-BB84-B3AA838834B4Q35767728-B83235B8-EDD7-4BDC-877D-38D92B869284Q35810461-44BAB313-27B4-4CBD-B021-BE81A91E5D68Q35913042-2F4B58D8-526C-485A-8277-151161BF79EFQ35937517-16F0CAC7-DD7D-402A-A1F5-597A170092F0Q35996102-4A2363FD-701E-4FE1-A4B9-8E9769DA7FC7Q35998823-E8FFCC53-F059-40F8-B978-98E697F315C1Q36014165-7A962853-BB26-4EE3-A0FE-01CD0F4BD64EQ36135533-56FCCCB3-34A8-44B8-ABC3-5F746C07BF99Q36167042-5EA49914-72C2-40AB-95BD-40106BBDAFF1Q36301400-E830B3E6-BC93-47E6-BC80-E658F85605D5Q36342845-EBA00943-9806-491C-88DC-BD0C5309D160Q36355920-78817A9C-4B7E-4B1C-97F3-765CC0E74634Q36404083-8A30B577-1FEA-4EAD-8405-E4502EF4FAD1Q36414198-9AEC9746-DF26-4F1D-8B6E-5F044D360189Q36586155-622C470C-4A11-43D9-A604-C37332D582B5Q37269473-A11A8E43-5934-4F8F-820D-215F00E90D72Q37404690-6C2C8E85-429E-4598-BBAE-DBF0551A457FQ37580410-08455873-9F43-418F-AEFA-9B9041A1BF50Q37736978-0A6A2834-D043-4EAC-A00A-12DD23BCC40EQ38402811-8E05B061-C74B-474F-AAA0-42F564689283Q38679628-7405493A-D97C-44C9-A6CF-DA564F6ECDE5Q38694309-78C13F65-6A16-4892-AB4C-14EB8BBE968CQ38828314-B0FA4F74-85D3-4438-AE9C-68CD9EB8A570Q38850529-F431350B-8096-4CB2-8935-6F3F1C546BE7Q39244943-8CFF471A-D544-4F45-B69B-880AF8655C01Q39641416-A5950EF4-2D16-4A35-949F-86F129BFBC97Q40084048-33990FB2-5C93-46E8-B3C4-08E6D7316725Q40513502-20EF48BD-A547-42E2-A68F-4DC05E2C4B2DQ41573792-71649F68-8011-4EE9-BC5B-D00A670785ACQ41672200-80B82676-BC30-47DC-AA9E-10B1CA259031Q46030309-0C2DF08C-9227-497E-9447-4E445DEE51AFQ47162466-4C38EB5C-017C-49A5-966B-BBD8F65766C8
P2860
Clinical next-generation sequencing in patients with non-small cell lung cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Clinical next-generation sequencing in patients with non-small cell lung cancer.
@en
Clinical next-generation sequencing in patients with non-small cell lung cancer.
@nl
type
label
Clinical next-generation sequencing in patients with non-small cell lung cancer.
@en
Clinical next-generation sequencing in patients with non-small cell lung cancer.
@nl
prefLabel
Clinical next-generation sequencing in patients with non-small cell lung cancer.
@en
Clinical next-generation sequencing in patients with non-small cell lung cancer.
@nl
P2093
P2860
P356
P1433
P1476
Clinical next-generation sequencing in patients with non-small cell lung cancer.
@en
P2093
Andrew J Bredemeyer
Catherine E Cottrell
Daniel Morgensztern
David H Spencer
Eric J Duncavage
Hussam Al-Kateb
John D Pfeifer
Kalin Guebert
Karen Seibert
Maria Baggstrom
P2860
P304
P356
10.1002/CNCR.29089
P407
P577
2014-10-24T00:00:00Z